Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GPR84 | Q9NQS5 | 2/20 | 0.54 |
| ▸ | FFAR1 | O14842 | 1/20 | 0.51 |
| ▸ | MGAM | O43451 | 5/20 | 0.50 |
| ▸ | GAA | P10253 | 5/20 | 0.50 |
| ▸ | SI | P14410 | 5/20 | 0.50 |
| ▸ | MGAM2 | Q2M2H8 | 5/20 | 0.50 |
| ▸ | MAPT | P10636 | 3/20 | 0.50 |
| ▸ | MEN1 | O00255 | 3/20 | 0.50 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.50 |
| ▸ | PKM | P14618 | 1/20 | 0.50 |
| ▸ | HDAC3 | O15379 | 1/20 | 0.49 |
| ▸ | HDAC4 | P56524 | 1/20 | 0.49 |
| ▸ | HDAC1 | Q13547 | 1/20 | 0.49 |
| ▸ | HDAC7 | Q8WUI4 | 1/20 | 0.49 |
| ▸ | HDAC2 | Q92769 | 1/20 | 0.49 |
| ▸ | HDAC10 | Q969S8 | 1/20 | 0.49 |
| ▸ | HDAC11 | Q96DB2 | 1/20 | 0.49 |
| ▸ | HDAC8 | Q9BY41 | 1/20 | 0.49 |
| ▸ | HDAC6 | Q9UBN7 | 1/20 | 0.49 |
| ▸ | HDAC9 | Q9UKV0 | 1/20 | 0.49 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13528266 | 0.87 | KMT2A (0.50) | GPR84FFAR1MGAMGAASI | |
| SCHEMBL15290787 | 0.86 | MAPT (0.50) | GPR84FFAR1MGAMGAASI | |
| SCHEMBL13247995 | 0.86 | HDAC3 (0.49) | GPR84FFAR1MGAMGAASI | |
| SCHEMBL8418334 | 0.84 | MAPT (0.49) | GPR84MGAMGAASIMGAM2 | |
| SCHEMBL15290795 | 0.83 | HDAC3 (0.49) | GPR84FFAR1MGAMGAASI | |
| SCHEMBL8418352 | 0.83 | ACE (0.46) | GPR84MGAMGAASIMGAM2 | |
| SCHEMBL8415706 | 0.83 | ACE (0.46) | GPR84MGAMGAASIMGAM2 | |
| SCHEMBL9947471 | 0.78 | GPR84 (0.54) | GPR84FFAR1MGAMGAASI | |
| SCHEMBL30873796 | 0.78 | CTSL (0.53) | GAAMAPTMEN1KMT2APKM | |
| SCHEMBL11636711 | 0.78 | CTSL (0.53) | GAAMAPTMEN1KMT2APKM |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8546356-B2 | Administration form of osteogenic protein complexes | ADOCIA (FR) | 2013-10-01 | — | — | US | disclosed |
| US-8497253-B2 | — | — | 2013-07-30 | — | — | US | disclosed |
| US-8497253-B2 | — | — | 2013-07-30 | — | — | US | disclosed |
| US-20100166867-A1 | Novel administration form of osteogenic protein complexes | ADOCIA (FR) | 2010-07-01 | — | — | US | disclosed |
| US-7335726-B2 | Lipopeptide stereoisomers, methods for preparing same and useful intermediates | CUBIST PHARMACEUTICALS, INC. (US) | 2008-02-26 | — | — | US | disclosed |
| US-20060223983-A1 | Lipopeptide stereoisomers, methods for preparing same and useful intermediates | CUBIST PHARMACEUTICALS, INC. | 2006-10-05 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100166867-A1 | Novel administration form of osteogenic protein complexes | BMP2, SOST, SDF4 | GPR84 3197/4885FFAR1 4553/4885MGAM 1442/4885 |
| US-20060223983-A1 | Lipopeptide stereoisomers, methods for preparing same and useful intermediates | NGLY1, LSS, NRDC | GPR84 2720/4885FFAR1 839/4885MGAM 2285/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.